Related Experiment Video

Updated: Aug 1, 2026

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator

Wang1, Chen, Yazdani

  • 1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

Journal of Thrombosis and Thrombolysis
|April 15, 2000
PubMed

Insights

Interleukin-4 (IL-4) enhances platelet-derived growth factor (PDGF)-induced urokinase-type plasminogen activator (u-PA) production in human aortic smooth muscle cells (SMCs). This modulation of u-PA by IL-4 impacts vascular cell function.

Area of Science:

  • Vascular Biology
  • Cell Signaling
  • Immunology

Background:

  • Platelet-derived growth factor (PDGF) promotes smooth muscle cell (SMC) migration by increasing tissue plasminogen activator (t-PA) production.
  • Interleukin-4 (IL-4) is a T-cell lymphokine with known roles in immune responses.
  • Understanding growth factor and lymphokine interactions is crucial for vascular health research.

Purpose of the Study:

  • To investigate the effect of IL-4 on PDGF-induced production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human aortic SMCs.
  • To determine if IL-4 modulates the expression of key components of the plasminogen activator system in response to PDGF stimulation.

Main Methods:

  • Human aortic SMCs were treated with PDGF (100 ng/mL) alone or in combination with IL-4 (500 U/mL).
  • Enzyme-linked immunosorbent assays (ELISAs) were used to measure u-PA and PAI-1 antigen levels in cellular lysates and conditioned media.
  • Quantitative analysis of protein expression was performed to assess treatment effects.

Main Results:

  • IL-4 significantly increased u-PA antigen levels in human aortic SMCs when co-incubated with PDGF compared to PDGF alone.
  • Coincubation with IL-4 did not significantly alter u-PA antigen levels within cellular lysates.
  • IL-4 did not significantly affect PAI-1 antigen levels in either conditioned media or cellular lysates.

Conclusions:

  • Interleukin-4 (IL-4) plays a role in modulating vascular SMC responses to PDGF.
  • IL-4 enhances PDGF-induced u-PA production in human aortic SMCs, suggesting a specific regulatory mechanism.
  • These findings contribute to understanding the complex interplay between growth factors and immune mediators in vascular SMCs.

More Related Videos

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...